Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 316

1.

A prototype approach toward antipsychotic medication adherence in schizophrenia.

Freudenreich O, Tranulis C.

Harv Rev Psychiatry. 2009;17(1):35-40. doi: 10.1080/10673220902724565.

PMID:
19205965
2.

Attitudes toward antipsychotic medication: the impact of clinical variables and relationships with health professionals.

Day JC, Bentall RP, Roberts C, Randall F, Rogers A, Cattell D, Healy D, Rae P, Power C.

Arch Gen Psychiatry. 2005 Jul;62(7):717-24.

PMID:
15997012
3.

An RCT of adherence therapy for people with schizophrenia in Chiang Mai, Thailand.

Maneesakorn S, Robson D, Gournay K, Gray R.

J Clin Nurs. 2007 Jul;16(7):1302-12.

PMID:
17584349
4.

A prospective study of risk factors for nonadherence with antipsychotic medication in the treatment of schizophrenia.

Ascher-Svanum H, Zhu B, Faries D, Lacro JP, Dolder CR.

J Clin Psychiatry. 2006 Jul;67(7):1114-23.

PMID:
16889456
5.

[Therapeutic alliance, a stake in schizophrenia].

Charpentier A, Goudemand M, Thomas P.

Encephale. 2009 Feb;35(1):80-9. doi: 10.1016/j.encep.2007.12.009. Epub 2008 May 19. Review. French.

PMID:
19250998
6.

Lack of insight in schizophrenia: impact on treatment adherence.

Buckley PF, Wirshing DA, Bhushan P, Pierre JM, Resnick SA, Wirshing WC.

CNS Drugs. 2007;21(2):129-41. Review.

PMID:
17284095
7.

[Compliance in schizophrenia: predictive factors, therapeutical considerations and research implications].

Misdrahi D, Llorca PM, Lançon C, Bayle FJ.

Encephale. 2002 May-Jun;28(3 Pt 1):266-72. French.

PMID:
12091789
8.

How do socio-demographic and clinical factors interact with adherence attitude profiles in schizophrenia? A cluster-analytical approach.

Beck EM, Cavelti M, Wirtz M, Kossowsky J, Vauth R.

Psychiatry Res. 2011 May 15;187(1-2):55-61. doi: 10.1016/j.psychres.2010.10.012. Epub 2010 Nov 12.

PMID:
21074860
9.

Assessment of adherence problems in patients with serious and persistent mental illness: recommendations from the Expert Consensus Guidelines.

Velligan DI, Weiden PJ, Sajatovic M, Scott J, Carpenter D, Ross R, Docherty JP.

J Psychiatr Pract. 2010 Jan;16(1):34-45. doi: 10.1097/01.pra.0000367776.96012.ca. Review.

PMID:
20098229
10.

Adherence and nonadherence to antipsychotic medications.

Kozuki Y, Schepp KG.

Issues Ment Health Nurs. 2005 May;26(4):379-96.

PMID:
16020055
11.

Substance abuse and the management of medication nonadherence in schizophrenia.

Wilk J, Marcus SC, West J, Countis L, Hall R, Regier DA, Olfson M.

J Nerv Ment Dis. 2006 Jun;194(6):454-7.

PMID:
16772865
12.

Schizophrenic patients' subjective reasons for compliance and noncompliance with neuroleptic treatment.

Löffler W, Kilian R, Toumi M, Angermeyer MC.

Pharmacopsychiatry. 2003 May;36(3):105-12.

PMID:
12806568
13.

Medication adherence and long-term functional outcomes in the treatment of schizophrenia in usual care.

Ascher-Svanum H, Faries DE, Zhu B, Ernst FR, Swartz MS, Swanson JW.

J Clin Psychiatry. 2006 Mar;67(3):453-60.

PMID:
16649833
14.

Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literature.

Lacro JP, Dunn LB, Dolder CR, Leckband SG, Jeste DV.

J Clin Psychiatry. 2002 Oct;63(10):892-909. Review.

PMID:
12416599
15.

Medication supervision and adherence of persons with psychotic disorders in residential treatment settings: a pilot study.

Grunebaum MF, Weiden PJ, Olfson M.

J Clin Psychiatry. 2001 May;62(5):394-9; quiz 400-1. Erratum in: J Clin Psychiatry 2001 Jun;62(6):480.

PMID:
11411825
16.

Impact of present and past antipsychotic side effects on attitude toward typical antipsychotic treatment and adherence.

Lambert M, Conus P, Eide P, Mass R, Karow A, Moritz S, Golks D, Naber D.

Eur Psychiatry. 2004 Nov;19(7):415-22.

PMID:
15504648
17.

Nonadherence to antipsychotic treatment in patients with schizophrenic disorders.

Svestka J, Bitter I.

Neuro Endocrinol Lett. 2007 Feb;28 Suppl 1:95-116. Review.

PMID:
17262005
18.

[Adherence to neuroleptic treatment of schizophrenic patients].

Blondiaux I, Alagille M, Ginestet D.

Encephale. 1988 Nov-Dec;14(6):431-8. Review. French.

PMID:
2906607
19.
20.

Subjective illness theory and antipsychotic medication compliance by patients with schizophrenia.

Holzinger A, Loffler W, Muller P, Priebe S, Angermeyer MC.

J Nerv Ment Dis. 2002 Sep;190(9):597-603.

PMID:
12357093

Supplemental Content

Support Center